Aminoquinoline derivatives and uses thereof
US11026943B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 12, 2017 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Jan 12, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are aminoquinoline and aminoacridine based hybrids, pharmaceutical compositions and medicaments that include such aminoquinoline and aminoacridine based hybrids, and methods of using such compounds for diagnosing and/or treating infections, neurodegenerative diseases or disorders, inflammation, inflammation associated diseases and disorders, and/or diseases or disorders that are treatable with dopamine agonists such as the restless leg syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.